Consumo de maní en niños alérgicos

1. Nwaru BI, Hickstein L, Panesar SS, etal. The epidemiology of food allergy in Europe: a systematic review and metaanalysis. Allergy 2014; 69:62-75.
2. Venter C, Hasan Arshad S, Grundy J,et al. Time trends in the prevalence of peanut allergy: three cohorts of children from the same geographical location in the UK. Allergy 2010; 65:103-8.
3. Sicherer SH, Muñoz-Furlong A, Godbold JH, Sampson HA. US prevalence of self-reported peanut, tree nut, and sesame allergy: 11-year follow-up. J Allergy Clin Immunol 2010; 125:1322-6.
4. Gray CL, Levin ME, Zar HJ, et al. Food allergy in South African children with atopic dermatitis. Pediatr Allergy Immunol 2014; 25:572-9.
5. Prescott SL, Pawankar R, Allen KJ, et al. A global survey of changing patterns of food allergy burden in children. World Allergy Org J 2013; 6:21.
6. Cummings AJ, Knibb RC, King RM, Lucas JS. The psychosocial impact of food allergy and food hypersensitivity in children, adolescents and their families: a review. Allergy 2010; 65:933-45.
7. Bock SA, Muñoz-Furlong A, Sampson HA. Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol2001; 107:191-3.
8. Hourihane JO, Kilburn SA, Dean P, Warner JO. Clinical characteristics of peanut allergy. Clan Exp Allergy 1997; 27: 634-9.
9. Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment. Peanut allergy. London: Department of Health, 1998 (http://webarchive.nationalarchives.gov.uk/20120209132957/http://cot.food.gov.uk/pdfs/cotpeanutall.pdf).
10. American Academy of Pediatrics, Committee on Nutrition. Hypoallergenic infant formulas. Pediatrics 2000; 106:346-9.
11. de Silva D, Geromi M, Halken S, et al. Primary prevention of food allergy in children and adults: systematic review. Allergy 2014; 69:581-9.
12. Greer FR, Sicherer SH, Burks AW. Effects of early nutritional interventions on the development of atopic disease in infants and children: the role of maternal dietary restriction, breastfeeding, timing of introduction of complementary foods, and hydrolyzed formulas. Pediatrics 2008; 121:183-91.
13. Boyce JA, Assa’ad A, Burks AW, et al. Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clan Immune 2010; 126: Suppl: S1-S58.
14. Du Toot G, Katz Y, Susiana P, et al. Early consumption of peanuts in infancy is associated with a low prevalence of peanut allergy. J Allergy Clan Immune 2008; 122:984-91.
15. Stride J, Thomson M, Hurricane J,Kimber I, Strobel S. A novel model of sensitization and oral tolerance to peanut protein. Immunology 2004; 113:293-303.
16. Palmer DJ, Metcalfe J, Makrides M, et al. Early regular egg exposure in infants with eczema: a randomized controlled trial. J Allergy Clin Immunol 2013; 132:387-92.
17. Nurmatov U, Venderbosch I, Devereux G, Simons FE, Sheikh A. Allergen-specific oral immunotherapy for peanut allergy. Cochrane Database Syst Rev 2012; 9:CD009014.
18. Jones SM, Burks AW, Dupont C. State of the art on food allergen immunotherapy: oral, sublingual, and epicutaneous. J Allergy Clin Immunol 2014; 133:318-23.
19. Burks AW, Jones SM, Wood RA, et al. Oral immunotherapy for treatment of egg allergy in children. N Engle J Med 2012; 367:233-43.
20. Varshney P, Jones SM, Scurlock AM, et al. A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response. J Allergy Clin Immunol 2011; 127:654-60.
21. Du Toit G, Roberts G, Sayre PH, et al. Identifying infants at high risk of peanut allergy: the Learning Early about Peanut Allergy (LEAP) screening study. J Allergy Clin Immunol 2013; 131:135-43.
22. Sofianou-Katsoulis A, Mesher D, Sasieni P, Du Toit G, Fox AT, Lack G. Assessing peanut consumption in a population of mothers and their children in the UK. World Allergy Organ J 2011; 4:38-44.
23. Brough HA, Makinson K, Penagos M, et al. Distribution of peanut protein in the home environment. J Allergy Clin Immunol2013; 132:623-9.
24. Brough HA, Santos AF, Makinson K, et al. Peanut protein in household dust is related to household peanut consumption and is biologically active. J Allergy Clin Immunol 2013; 132:630-8.
25. Lieberman JA, Sicherer SH. Diagnosis of food allergy: epicutaneous skin tests, in vitro tests, and oral food challenge. Curr Allergy Asthma Rep 2011; 11:58-64.
26. Vickery BP, Lin J, Kulis M, et al. Peanut oral immunotherapy modifies IgE and IgG4 responses to major peanut allergens. J Allergy Clin Immunol 2013; 131:128-34.
27. Savilahti EM, Kuitunen M, Savilahti E, Mäkelä MJ. Specific antibodies in oral immunotherapy for cow’s milk allergy: kinetics and prediction of clinical outcome. Int Arch Allergy Immunol 2014; 164:32-9.
28. Vickery BP, Scurlock AM, Kulis M, et al. Sustained unresponsiveness to peanutin subjects who have completed peanutoral immunotherapy. J Allergy Clin Immunol2014; 133:468-75.
29. Nouri-Aria KT, Wachholz PA, Francis JN, et al. Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity. J Immunol2004; 172:3252-9.
30. Santos AF, James LK, Bahnson HT, e tal. IgG4 inhibits peanut-induced basophil and mast cell activation in peanut-tolerant children sensitized to peanut major allergens. J Allergy Clin Immunol (in press).
31. Fox DE, Lack G. Peanut allergy. Lancet1998; 352:741. [Erratum, Lancet 1998;352:1557.]